Assuntos
Eosinofilia/induzido quimicamente , Sinvastatina/efeitos adversos , Adulto , Feminino , HumanosAssuntos
Antialérgicos/uso terapêutico , Dessensibilização Imunológica/métodos , Hipersensibilidade a Ovo/terapia , Hipersensibilidade a Leite/terapia , Omalizumab/uso terapêutico , Alérgenos/imunologia , Animais , Bovinos , Criança , Pré-Escolar , Terapia Combinada , Hipersensibilidade a Ovo/imunologia , Proteínas do Ovo/imunologia , Feminino , Humanos , Imunoglobulina E/sangue , Masculino , Hipersensibilidade a Leite/imunologia , Proteínas do Leite/imunologia , Resultado do TratamentoRESUMO
The introduction of new diagnostic and therapeutic procedures involving allergen exposure may increase the risk of allergic reactions. We designed and distributed an anonymous questionnaire among the allergy units of the Valencian Community in order to collect information on measures to ensure clinical safety. Twelve hospital outpatient clinics and 8 ambulatory care centres reported similar patterns of activities, including the use of critical care units, emergency rooms or day hospitals for higher risk techniques. The provision of security-related instruments is broader in hospital outpatient clinics and included: oxygen (91.7%), pulse oximeter (75.0%) or vital signs monitor (8.3%), resuscitation material (91.7%) and defibrillator (83.3%). The response time for emergencies is set in 50% of clinics. The resuscitation material is systematically reviewed and informed consent signed. Security is more limited in ambulatory care centres. It is necessary to set down the conditions for clinical safety in allergology. Key words. Allergy. Ambulatory care. Clinical safety. Health services. Hospital outpatient clinic.